Skip Navigation


Human Molecular Genetics Advance Access originally published online on January 20, 2009
Human Molecular Genetics 2009 18(7):1288-1300; doi:10.1093/hmg/ddp028
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
18/7/1288    most recent
ddp028v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Guenther, U.-P.
Right arrow Articles by Fischer, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guenther, U.-P.
Right arrow Articles by Fischer, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1)

Ulf-Peter Guenther1,2,{dagger}, Lusy Handoko3,{dagger}, Bernhard Laggerbauer3, Sibylle Jablonka4, Ashwin Chari3, Mona Alzheimer4, Jürgen Ohmer3, Oliver Plöttner3, Niels Gehring6, Albert Sickmann5, Katja von Au1, Markus Schuelke1,7 and Utz Fischer3,*

1 Department of Neuropediatrics, Charité University Hospital, D-13353 Berlin, Germany 2 Department of Biology, Chemistry and Pharmacy, Free University Berlin, D-14195 Berlin, Germany 3 Theodor-Boveri-Institute 4 Institute for Clinical Neurobiology, University of Würzburg, D-97074 Würzburg, Germany 5 Rudolf-Virchow-Center for Experimental Biomedicine, University of Würzburg, D-97078 Würzburg, Germany 6 University of Heidelberg, Im Neuheimer Feld 156, D-69120 Heidelberg, Germany 7 NeuroCure Clinical Research Center, Charité University Hospital, D-10117 Berlin, Germany

* To whom correspondence should be addressed. Tel: +49 931 888 4029; Fax: +49 931 4026; Email: utz.fischer{at}biozentrum.uni-wuerzburg.de

Received November 22, 2008; Accepted January 13, 2009

Distal spinal muscular atrophy type 1 (DSMA1) is an autosomal recessive disease that is clinically characterized by distal limb weakness and respiratory distress. In this disease, the degeneration of {alpha}-motoneurons is caused by mutations in the immunoglobulin µ-binding protein 2 (IGHMBP2). This protein has been implicated in DNA replication, pre-mRNA splicing and transcription, but its precise function in all these processes has remained elusive. We have purified catalytically active recombinant IGHMBP2, which has enabled us to assess its enzymatic properties and to identify its cellular targets. Our data reveal that IGHMBP2 is an ATP-dependent 5'->3' helicase, which unwinds RNA and DNA duplices in vitro. Importantly, this helicase localizes predominantly to the cytoplasm of neuronal and non-neuronal cells and associates with ribosomes. DSMA1-causing amino acid substitutions in IGHMBP2 do not affect ribosome binding yet severely impair ATPase and helicase activity. We propose that IGHMBP2 is functionally linked to translation, and that mutations in its helicase domain interfere with this function in DSMA1 patients.


{dagger} These authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
M. de Planell-Saguer, D. G. Schroeder, M. C. Rodicio, G. A. Cox, and Z. Mourelatos
Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery
Hum. Mol. Genet., June 15, 2009; 18(12): 2115 - 2126.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.